Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro

Lignende værker

• Antitumor Activity of Emodin against Pancreatic Cancer Depends on Its Dual Role: Promotion of Apoptosis and Suppression of Angiogenesis
  af: Lin, Sheng-Zhang, et al.
  Udgivet: (2012)
• Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
  af: Wei, Wei-Tian, et al.
  Udgivet: (2011)
• Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway
  af: Tong, Hongfei, et al.
  Udgivet: (2020)
• Protective Effects of Emodin-Induced Neutrophil Apoptosis via the Ca(2+)-Caspase 12 Pathway against SIRS in Rats with Severe Acute Pancreatitis
  af: Wang, Gui-Jun, et al.
  Udgivet: (2016)
• Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression
  af: Guo, Hongchun, et al.
  Udgivet: (2020)